Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.

Between January 1, 2021 and May 31, 2022, there were approximately 30.6 thousand deaths involving COVID-19 among 80 to 89 year olds in England, with over 14 thousand deaths occurring among unvaccinated people in this age group. Across all the age groups in the provided time interval, deaths involving COVID-19 among the unvaccinated population was around double the amount of people who received at least two doses of a vaccine. For further information about the COVID-19 pandemic, please visit our dedicated Facts and Figures page.

Coronavirus (COVID-19) vaccination rates among adults who live in England, including estimates by socio-demographic characteristic and Standard Occupational Classification (SOC) 2020

As of January 18, 2023, Portugal had the highest COVID-19 vaccination rate in Europe having administered 272.78 doses per 100 people in the country, while Malta had administered 258.49 doses per 100. The UK was the first country in Europe to approve the Pfizer/BioNTech vaccine for widespread use and began inoculations on December 8, 2020, and so far have administered 224.04 doses per 100. At the latest data, Belgium had carried out 253.89 doses of vaccines per 100 population. Russia became the first country in the world to authorize a vaccine - named Sputnik V - for use in the fight against COVID-19 in August 2020. As of August 4, 2022, Russia had administered 127.3 doses per 100 people in the country.

The seven-day rate of cases across Europe shows an ongoing perspective of which countries are worst affected by the virus relative to their population. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

This dataset illustrates uptake inequalities of fourth doses of the coronavirus (COVID-19) vaccine using 2021 Census-derived demographic and socio-economic characteristics: age. sex, ethnicity, religion, socio-economic status and self-reported disability and health status.

Vaccination data are produced using linked data from Deaths registrations and Census 2021, National Immunisation Management Service, Hospital Episode Statistics and General Practise Extraction Service data for Pandemic Planning and Research.

Data may differ from weekly administrative vaccination data published by NHS England.

As of July 17, 2022, it was estimated that around every person aged 75 to 79 years of age in England had received at least two doses of a COVID-19 vaccine. Although the source does mention that this is likely to be an overestimation due to population figures taken from 2020. The data shows that at least a quarter of men under 30 years of age have not yet had two vaccine doses, with women more likely to be vaccinated among younger age groups.

As of July 13, 2022, approximately 53.7 million people in the United Kingdom had received the first dose of the COVID-19 vaccination. The UK was the first country in the world to approve the use of the Pfizer/BioNTech vaccine, and began inoculations on December 8, 2020. Nearly all the vaccines currently being used in the UK require two doses for full efficacy to occur, and according to the latest data around 50.3 million people had received their second dose of the immunization. Furthermore, 40.1 million booster vaccinations had been administered.

The total number of cases in the UK can be found here. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Estimates of the risk of hospital admission for coronavirus (COVID-19) and death involving COVID-19 by vaccination status, overall and by age group, using anonymised linked data from Census 2021. Experimental Statistics.

Outcome definitions

For this analysis, we define a death as involving COVID-19 if either of the ICD-10 codes U07.1 (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified) is mentioned on the death certificate. Information on cause of death coding is available in the User Guide to Mortality Statistics. We use date of occurrance rather than date of registration to give the date of the death.

We define COVID-109 hospitalisation as an inpatient episode in Hospital Episode Statistics where the primary diagnosis was COVID-19, identified by the ICD-19 codes (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified). Where an individual had experienced more than one COVID-19 hospitalisation, the earliest that occurred within the study period was used. We define the date of COVID-19 hospitalisation as the start of the hospital episode.

ICD-10 code

U07.1 :

COVID-19, virus identified

U07.2:

COVID-19, virus not identified

Vaccination status is defined by the dose and the time since the last dose received

Unvaccinated:

no vaccination to less than 21 days post first dose

First dose 21 days to 3 months:

more than or equal to 21 days post second dose to earliest of less than 91 days post first dose or less than 21 days post second dose

First dose 3+ months:

more than or equal to 91 days post first dose to less than 21 days post second dose

Second dose 21 days to 3 months:

more than or equal to 21 days post second dose to earliest of less than 91 days post second dose or less than 21 days post third dose

Second dose 3-6 months:

more than or equal to 91 days post second dose to earliest of less than 182 days post second dose or less than 21 days post third dose

Second dose 6+ months:

more than or equal to 182 days post second dose to less than 21 days post third dose

Third dose 21 days to 3 months:

more than or equal to 21 days post third dose to less than 91 days post third dose

Third dose 3+ months:

more than or equal to 91 days post third dose

Model adjustments

Three sets of model adjustments were used

Age adjusted:

age (as a natural spline)

Age, socio-demographics adjusted:

age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status)

Fully adjusted:

age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status), plus health-related characteristics (disability, self-reported health, care home residency, number of QCovid comorbidities (grouped), BMI category, frailty flag and hospitalisation within the last 21 days.

Age

Age in years is defined on the Census day 2021 (21 March 2021). Age is included in the model as a natural spline with boundary knots at the 10th and 90th centiles and internal knots at the 25th, 50th and 75th centiles. The positions of the knots are calculated separately for the overall model and for each age group for the stratified model.

Time Use Survey data show changes in how people spent their time during coronavirus (COVID-19) restrictions in March and April 2020, September to October 2020 and March 2021, as well as before the pandemic. It also includes Opinions and Lifestyle Survey data on behaviours following vaccination in Great Britain from 19 May to 13 June 2021.

Estimates of the risk of all-cause and cardiac death in the 12 weeks after vaccination or positive SARS-CoV-2 test compared with subsequent weeks for people aged 12 to 29 years in England using two sources of mortality data: ONS death registrations and deaths recorded in Hospital Episode Statistics. 8 December 2020 to 25 May 2022. Experimental Statistics.

A January 2022 survey explored opinions on whether sportspeople should have to disclose their coronavirus (COVID-19) vaccination status in Great Britain. Opinions were generally divided. While ** percent of respondents said sports professionals should disclose their vaccine status, ** percent said athletes should not have to.

This statistical report, co-authored with the UK Health Security Agency (UKSHA), reports childhood vaccination coverage statistics for England in 2023-24. Data relates to the routine vaccinations offered to all children up to the age of 5 years, derived from the Cover of Vaccination Evaluated Rapidly (COVER). Additional information on children aged 2 and 3 vaccinated against seasonal flu are collected from GPs through UKHSA's ImmForm system.

Estimates of the risk of hospital admission for coronavirus (COVID-19) and death involving COVID-19 by vaccination status, in England, using anonymised linked data from Census 2021. Vaccine effectiveness estimates are given for the whole study population and stratified by age groups. Experimental Statistics.

This statistical report, co-authored with Public Health England (PHE), reports childhood vaccination coverage statistics for England in 2019-20. Data relates to the routine vaccinations offered to all children up to the age of five years, derived from the Cover of Vaccination Evaluated Rapidly (COVER). Additional information on children aged 2 and 3 vaccinated against seasonal flu are collected from GPs through PHE's ImmForm system.

Antibody data, by UK country and age, from the Coronavirus (COVID-19) Infection Survey.

Data from the Opinions and Lifestyle Survey (OPN) on whether and where someone has had to prove they have received a coronavirus (COVID-19) vaccine or had a negative test result, on worries about children returning to school including the reasons why and peoples perceptions of their risk of catching COVID-19, covering the period 8 to 19 September 2021.

The number of COVID-19 vaccination doses administered in the United Kingdom rose to 151248820 as of Oct 27 2023. This dataset includes a chart with historical data for the United Kingdom Coronavirus Vaccination Total.